ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in San Diego, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Endometrial Cancer
Squamous Cell Carcinoma of Head and Neck
Non-Small-Cell Lung Carcinoma
Ovarian Cancer

Breast Cancer trials near San Diego, CA, USA:

ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer (TACTIVE-E)

A phase 1b study to assess the combination of ARV-471 and everolimus in participants with advanced or metastatic ER+/HER2- breast cancer...

Active, not recruiting
Breast Cancer
Drug: ARV-471 in combination with Everolimus

Phase 1

Arvinas
Arvinas

San Diego, California, United States and 8 other locations

This study will compare DS 8201a to standard treatment.Participants must have HER2 breast cancer that has been treated before.Their ...

Active, not recruiting
Breast Cancer
Drug: Trastuzumab
Drug: Trastuzumab deruxtecan

Phase 3

Daiichi Sankyo
Daiichi Sankyo

San Diego, California, United States and 226 other locations

A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....

Enrolling
Advanced Breast Cancer
Drug: ARV-471
Drug: Fulvestrant

Phase 3

Pfizer
Pfizer

Encinitas, California, United States and 324 other locations

Most physicians still use a one-size-fits-all approach to breast screening in which all women, regardless of their personal history, family ...

Enrolling
Breast Cancer
Breast Carcinoma in Situ
Other: Screening advice based on a basic risk assessment
Other: Complete a health questionnaire
University of California San Francisco (UCSF)
University of California San Francisco (UCSF)

San Diego, California, United States and 10 other locations

The purpose of this study will be to evaluate, in a multi-center setting, the ability of radiofrequency ablation (RFA) of breast cancer...

Active, not recruiting
Breast Cancer
Device: Radiofrequency Ablation
University of Arkansas
University of Arkansas

San Diego, California, United States and 5 other locations

oral immuno-oncology product candidate targeting immune-suppressive tumor-associated myeloid cells through selective inhibition of phosphoin...

Active, not recruiting
Breast Cancer
Renal Cell Carcinoma
Drug: nab-paclitaxel
Drug: Bevacizumab

Phase 2

Infinity Pharmaceuticals
Infinity Pharmaceuticals

San Diego, California, United States and 23 other locations

OKI-219-101 is a Phase 1a/1b, open-label, multicenter, dose-escalation study designed to evaluate the safety, tolerability, pharmacokinetics (PK), ph...

Enrolling
Advanced Cancer
Breast Cancer
Drug: Trastuzumab
Drug: Fulvestrant

Phase 1

OnKure

Encinitas, California, United States and 16 other locations

This study is designed to compare the anti-tumor activity as well as the safety and efficacy of DS-8201a versus T-DM1 in HER2-positive, unre ...

Active, not recruiting
Breast Cancer
Drug: Trastuzumab deruxtecan (T-DXd)
Drug: Ado-trastuzumab emtansine (T-DM1)

Phase 3

Daiichi Sankyo
Daiichi Sankyo

San Diego, California, United States and 163 other locations

Locations recently updated

The purpose of this trial is to inform the future clinical development of the two investigational agents in ER+ breast cancer, LEE0...

Active, not recruiting
Breast Cancer
Drug: BYL719
Drug: LEE011

Phase 1, Phase 2

Novartis
Novartis

San Diego, California, United States and 23 other locations

of fulvestrant or an aromatase inhibitor in women and men with breast cancer whose disease has advanced on one endocrine therapy in...

Enrolling
Breast Cancer
ER Positive Breast Cancer
Drug: Letrozole
Drug: Exemestane

Phase 3

Olema Pharmaceuticals

La Jolla, California, United States and 170 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems